1. The effects of
intravenous administration of
endothelin (ET) receptor antagonists
SB-209670 (0.001-10.0 mg kg(-1)),
SB-217242,
SB-234551 (0.01-10.0 mg kg(-1)) and
BQ-788 (0.001-1.0 mg kg(-1)) were investigated on trigeminal nerve
ganglion stimulation-induced neurovascular reflexes in the carotid vasculature of the anaesthetized cat. Comparisons were made with
sumatriptan (0.003-3.0 mg kg(-1)) and alpha-CGRP8-37 (0.001-0.1 mg kg(-1)). 2. Trigeminal nerve
ganglion stimulation produced frequency related increases in carotid blood flow, reductions in carotid vascular resistance and non-frequency related increases in blood pressure.
Guanethidine (3 mg kg(-1), i.v.) blocked trigeminal nerve
ganglion-induced increases in blood pressure but had no effect on changes in carotid flow or resistance. Maximal reductions in carotid vascular resistance was observed
at 10 Hz, and this frequency was selected to investigate the effects of drugs on trigeminal nerve
ganglion stimulation-induced responses in
guanethidine treated cats. 3. Saline, alpha-CGRP8-37
SB-209670 and
BQ-788 had little or no effect on resting haemodynamic parameters.
SB-217242 (10 mg kg(-1), n=3) produced a 56% reduction in arterial blood pressure whereas SB-233451 (10 mg kg(-1), n=3) produced a 30% reduction in carotid vascular resistance.
Sumatriptan produced dose-related reductions in resting carotid flow and increases (max. 104% at 0.3 mg kg(-1), n = 5) in vascular resistance. 4.
SB-209670 (n=6-7),
SB-217242 (n=3) and
BQ-788 (n=3) produced inhibition of trigeminal nerve
ganglion stimulation-induced reductions in carotid vascular resistance. Saline,
SB-234551, alpha-CGRP8-37 and
sumatriptan had no effect. 5. These data demonstrate ET(B) receptor blockade attenuates the
vasodilator effects of trigeminal nerve
ganglion stimulation in the carotid vascular bed of
guanethidine pretreated anaesthetized cats.